ABSI Live signals | Maximize Profits with Getagraph.com

BUY 151361 min ago

@ $4.70

Issued: 14 Feb 2024 @ 14:13

Return: -11.06%

Previous signal: Feb 13 - 11:04

Previous signal: Sell

Return: 12.71 %

Live Chart Being Loaded With Signals

Commentary (29 May 2024 @ 16:00):

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States...

Stats
Today's Volume	1.86M
Average Volume	1.20M
Market Cap	472.69M
EPS	$0 ( 2024-05-20 )
Next earnings date	( $-0.190 ) 2024-08-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.57
ATR14	$0.00800 (0.19%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-22	Phoenix Venture Partners Ii Lp	Sell	3 100 000	Common Stock
2024-03-19	Mcclain Sean	Buy	1 500 000	Common Stock
2024-03-01	Redmile Group, Llc	Buy	222 222	Common Stock
2023-12-31	Phoenix Venture Partners Ii Lp	Buy	0
2024-02-01	Bedrick Todd	Buy	20 570	Common Stock

INSIDER POWER
34.13
Last 93 transactions
Buy: 45 039 233 \| Sell: 10 230 968

Volume Correlation

Long: 0.44 (neutral)

Short: -0.38 (neutral)

Signal:(87.107) Neutral

Absci Corporation Correlation

10 Most Positive Correlations
OZEM	1
INDH	0.863
RR	0.817

10 Most Negative Correlations
HDL	-0.869

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Absci Corporation Correlation - Currency/Commodity

0.59
( weak )

0.47
( neutral )

0.00
( neutral )

0.60
( weak )

0.64
( weak )

-0.85
( strong negative )

Absci Corporation Financials

Annual	2023
Revenue:	$5.72M
Gross Profit:	$-8.28M (-144.82 %)
EPS:	$-1.200

FY	2023
Revenue:	$5.72M
Gross Profit:	$-8.28M (-144.82 %)
EPS:	$-1.200

FY	2022
Revenue:	$5.75M
Gross Profit:	$-7.29M (-126.85 %)
EPS:	$-1.150

FY	2021
Revenue:	$4.78M
Gross Profit:	$-1.87M (-39.15 %)
EPS:	$-1.117

Financial Reports:

No articles found.

Absci Corporation Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Absci Corporation

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.